Has the time come to declare video-assisted thoracic surgery lobectomy the standard of care for early stage lung cancer?

2017 ◽  
Vol 2 ◽  
pp. 66-66
Author(s):  
Steven Milman ◽  
Thomas Ng
Keyword(s):  
Lung Cancer ◽  
Thoracic Surgery ◽  
Early Stage ◽  
Standard Of Care ◽  
Early Stage Lung Cancer ◽  
Video Assisted Thoracic Surgery ◽  
Video Assisted ◽  
Stage Lung Cancer

scholarly journals Uni-portal and three-portal video-assisted thoracic surgery pulmonary lobectomy for early stage lung cancer (UNIT trial): study protocol of a single-center randomized trial

2021 ◽  
Author(s):  
Paolo Mendogni ◽  
Alessandra Mazzucco ◽  
Alessandro Palleschi ◽  
Lorenzo Rosso ◽  
Ilaria Righi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Pain ◽  
Thoracic Surgery ◽  
Early Stage ◽  
Pulmonary Lobectomy ◽  
Analgesic Drug ◽  
Early Stage Lung Cancer ◽  
Video Assisted Thoracic Surgery ◽  
Video Assisted ◽  
Stage Lung Cancer

Abstract BackgroundVideo-assisted thoracoscopic surgery (VATS) lobectomy is currently the recommended approach for treating early-stage non-small cell lung cancer (NSCLC). Different VATS approaches have been proposed so far, and the actual advantages of one technique over the other are still under debate. The aim of our study is to compare postoperative pain and analgesic drug consumption in uniportal VATS and triportal VATS for pulmonary lobectomy in early-stage lung cancer patients. MethodsThis study is a single-centre, prospective, two-arm, parallel-group, randomized controlled trial. It is designed to compare uniportal video-assisted thoracic surgery (u-VATS) and three-ports video-assisted thoracic surgery (t-VATS) in terms of post-operative pain. The trial will enrol 120 patients with a 1:1 randomization. The primary outcome is the assessment of analgesic drug consumption. Secondary outcomes are postoperative pain measurement, evaluation of postoperative pulmonary function, and metabolic recovery after pulmonary lobectomy. DiscussionThe choice of which VATS approach to adopt for treating patients undergoing pulmonary resection mostly depends on the surgeon’s preferences; therefore, it is hard to prove whether one VATS technique is superior to the other. Moreover, postoperative analgesic protocols vary consistently among different centres. To date, only a few studies have evaluated the effects of the most popular VATS techniques. There is no evidence about difference between multi-ports VATS and u-VATS in terms of postoperative pain. We hope that the results of our trial will provide valuable information on the outcomes of these different surgical approaches.Trial registrationClinicalTrials.gov. NCT03240250; registered 08/07/2017; retrospectively registered; https://clinicaltrials.gov/ct2/show/NCT03240250?term=NCT03240250&draw=2&rank=1

scholarly journals Uniportal and three-portal video-assisted thoracic surgery pulmonary lobectomy for early-stage lung cancer (UNIT trial): study protocol of a single-center randomized trial

Trials ◽  
2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Paolo Mendogni ◽  
Alessandra Mazzucco ◽  
Alessandro Palleschi ◽  
Lorenzo Rosso ◽  
Ilaria Righi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Postoperative Pain ◽  
Thoracic Surgery ◽  
Early Stage ◽  
Pulmonary Lobectomy ◽  
Analgesic Drug ◽  
Early Stage Lung Cancer ◽  
Video Assisted Thoracic Surgery ◽  
Video Assisted ◽  
Stage Lung Cancer

Abstract Background Video-assisted thoracoscopic surgery (VATS) lobectomy is currently the recommended approach for treating early-stage non-small cell lung cancer (NSCLC). Different VATS approaches have been proposed so far, and the actual advantages of one technique over the other are still under debate. The aim of our study is to compare postoperative pain and analgesic drug consumption in uniportal VATS and triportal VATS for pulmonary lobectomy in early-stage lung cancer patients. Methods This study is a single-center, prospective, two-arm, parallel-group, randomized controlled trial. It is designed to compare uniportal video-assisted thoracic surgery (u-VATS) and three-port video-assisted thoracic surgery (t-VATS) in terms of postoperative pain. The trial will enroll 120 patients with a 1:1 randomization. The primary outcome is the assessment of analgesic drug consumption. Secondary outcomes are postoperative pain measurement, evaluation of postoperative pulmonary function, and metabolic recovery after pulmonary lobectomy. Discussion The choice of which VATS approach to adopt for treating patients undergoing pulmonary resection mostly depends on the surgeon’s preferences; therefore, it is hard to prove whether one VATS technique is superior to the other. Moreover, postoperative analgesic protocols vary consistently among different centers. To date, only a few studies have evaluated the effects of the most popular VATS techniques. There is no evidence about the difference between multiport VATS and u-VATS in terms of postoperative pain. We hope that the results of our trial will provide valuable information on the outcomes of these different surgical approaches. Trial registration ClinicalTrials.gov NCT03240250. Registered on 07 August 2017; retrospectively registered.

scholarly journals Erratum to: Ten Years' Experience in Robotic-Assisted Thoracic Surgery for Early Stage Lung Cancer

2019 ◽  
Author(s):  
Monica Casiraghi ◽  
Domenico Galetta ◽  
Alessandro Borri ◽  
Adele Tessitore ◽  
Rosalia Romano ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Thoracic Surgery ◽  
Early Stage ◽  
Early Stage Lung Cancer ◽  
Robotic Assisted ◽  
Stage Lung Cancer
Sign in / Sign up

Export Citation Format

Share Document